XML 42 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Organization and Significant Accounting Policies - Additional Information (Detail)
12 Months Ended
Jul. 29, 2015
Jul. 01, 2006
shares
Dec. 31, 2016
USD ($)
Subsidiary
shares
Dec. 31, 2015
USD ($)
shares
Dec. 31, 2014
shares
Organization And Significant Accounting Policies [Line Items]          
Percentage of ownership in issued and outstanding shares of common stock parent Company     93.70%    
Common stock in subsidiary Company | shares   133,334      
Reverse stock split ratio 0.0067        
Reverse stock split ratio description     Effective July 29, 2015 and pursuant to the reverse stock split approved by the Company’s Board of Directors, each 150 shares of issued and outstanding common stock were combined into and became one share of common stock and no fractional shares were issued.    
Burn rate     $ 350,000    
Capital expenditures and patent costs     $ 79,000    
Revenue-generating subsidiaries | Subsidiary     2    
Revenues     $ 7,165,000 $ 7,551,000  
Original maturities period, maximum     3 months    
Allowance for doubtful accounts receivable     $ 12,000 20,000  
Patents and other intangible assets     4,277,000 3,894,000  
Accumulated amortization     793,000 671,000  
Impairment of intangible assets     $ 330,000 $ 176,000  
Period of right of return guarantee     30 days 30 days 30 days
Vested stock options outstanding | shares     217,762 191,519  
Stock options outstanding, non-vested | shares     1,293,044 60,120  
Warrants outstanding | shares     7,321,468 126,206 850,058
Warrants [Member]          
Organization And Significant Accounting Policies [Line Items]          
Number of common shares considered dilutive | shares       74,455  
Allowance for Sales Returns [Member]          
Organization And Significant Accounting Policies [Line Items]          
Allowance for sales returns     $ 10,000 $ 10,000  
Cell Technology [Member]          
Organization And Significant Accounting Policies [Line Items]          
Percentage of revenue contributed     60.00% 54.00%  
Skin Care [Member]          
Organization And Significant Accounting Policies [Line Items]          
Percentage of revenue contributed     40.00% 46.00%  
Warrants outstanding | shares     0 1,334 1,334
Research and Development [Member]          
Organization And Significant Accounting Policies [Line Items]          
Amortization expense     $ 122,000 $ 99,000  
Minimum [Member]          
Organization And Significant Accounting Policies [Line Items]          
Estimated useful life of property and equipment     3 years    
Maximum [Member]          
Organization And Significant Accounting Policies [Line Items]          
Estimated useful life of property and equipment     5 years    
Therapeutic [Member]          
Organization And Significant Accounting Policies [Line Items]          
Revenues     $ 0    
Clinical [Member]          
Organization And Significant Accounting Policies [Line Items]          
Revenues     $ 0